Kelly Thomas Patrick

Chief Financial Officer at Deciphera Pharmaceuticals, Inc.

Sold, on record
$6.5M
Dollars the filings state
Form 4 sales
24
Latest Feb 16, 2024
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale Deciphera Pharmaceuticals, Inc.Plan not stated
    Jun 16, 2022 2022

    Sold 1,768 shares at $10.75 ($19k)

    Kelly Thomas Patrick, Chief Financial Officer

    Sold 3.7% of holdings ($514k position)46,080 shares left0.8x usual sizeFiling

  2. 2 Form 4 sale Deciphera Pharmaceuticals, Inc.Plan not stated
    Jan 17, 2023 +215 days

    Sold 2,403 shares at $21.24 ($51k)

    Kelly Thomas Patrick, Chief Financial Officer

    Sold 5.2% of holdings ($979k position)43,677 shares left1.8x usual sizeFiling

  3. 3 Form 4 sale Deciphera Pharmaceuticals, Inc.Plan not stated
    Feb 16, 2023 +30 days

    Sold 1,370 shares at $15.10 ($21k)

    Kelly Thomas Patrick, Chief Financial Officer

    Sold 2.3% of holdings ($908k position)58,795 shares left0.9x usual sizeFiling

  4. 4 Form 4 sale Deciphera Pharmaceuticals, Inc.No plan
    Jun 16, 2023 +120 days

    Sold 1,655 shares at $14.40 ($24k)

    Kelly Thomas Patrick, Chief Financial Officer

    No 10b5-1 planSold 2.8% of holdings ($847k position)57,140 shares left1.1x usual sizeFiling

  5. 5 Form 4 sale Deciphera Pharmaceuticals, Inc.No plan
    Oct 30, 2023 +136 days

    Sold 2,316 shares at $12.02 ($28k)

    Kelly Thomas Patrick, Chief Financial Officer

    No 10b5-1 planSold 3.5% of holdings ($786k position)63,068 shares left1.4x usual sizeFiling

  6. 6 Form 4 sale Deciphera Pharmaceuticals, Inc.No plan
    Dec 13, 2023 +44 days

    Sold 2,792 shares at $15.37 ($43k)

    Kelly Thomas Patrick, Chief Financial Officer

    No 10b5-1 planSold 3.9% of holdings ($1.1M position)68,520 shares left1.6x usual sizeFiling

  7. 7 Form 4 sale Deciphera Pharmaceuticals, Inc.No plan
    Jan 16, 2024 +34 days

    Sold 2,435 shares at $14.47 ($35k)

    Kelly Thomas Patrick, Chief Financial Officer

    No 10b5-1 planSold 3.6% of holdings ($991k position)66,085 shares left1.4x usual sizeFiling

  8. 8 Form 4 sale Deciphera Pharmaceuticals, Inc.No plan
    Feb 16, 2024 +31 days

    Sold 3,010 shares at $15.62 ($47k)

    Kelly Thomas Patrick, Chief Financial Officer

    No 10b5-1 planSold 3.6% of holdings ($1.3M position)80,350 shares left1.5x usual sizeFiling

Every transaction

Loading transactions…

Sales and notices (24)

Form 144 notices and Form 4 sales by Kelly Thomas Patrick
Source
Feb 16, 2024Feb 20, 2024Deciphera Pharmaceuticals, Inc.Chief Financial OfficerForm 4 sale3,010$47k3.6%No planSEC
Jan 16, 2024Jan 18, 2024Deciphera Pharmaceuticals, Inc.Chief Financial OfficerForm 4 sale2,435$35k3.6%No planSEC
Dec 13, 2023Dec 14, 2023Deciphera Pharmaceuticals, Inc.Chief Financial OfficerForm 4 sale2,792$43k3.9%No planSEC
Oct 30, 2023Oct 31, 2023Deciphera Pharmaceuticals, Inc.Chief Financial OfficerForm 4 sale2,316$28k3.5%No planSEC
Jun 16, 2023Jun 21, 2023Deciphera Pharmaceuticals, Inc.Chief Financial OfficerForm 4 sale1,655$24k2.8%No planSEC
Feb 16, 2023Feb 17, 2023Deciphera Pharmaceuticals, Inc.Chief Financial OfficerForm 4 sale1,370$21k2.3%Plan not statedSEC
Jan 17, 2023Jan 19, 2023Deciphera Pharmaceuticals, Inc.Chief Financial OfficerForm 4 sale2,403$51k5.2%Plan not statedSEC
Jun 16, 2022Jun 21, 2022Deciphera Pharmaceuticals, Inc.Chief Financial OfficerForm 4 sale1,768$19k3.7%Plan not statedSEC
Feb 16, 2022Feb 18, 2022Deciphera Pharmaceuticals, Inc.Chief Financial OfficerForm 4 sale1,368$12k2.8%Plan not statedSEC
Feb 16, 2021Feb 18, 2021Deciphera Pharmaceuticals, Inc.Chief Financial OfficerForm 4 sale524$26k7.4%Plan not statedSEC
Sep 14, 2020Sep 16, 2020Deciphera Pharmaceuticals, Inc.Chief Financial OfficerForm 4 sale3,000$150k29.9%UnusualSEC
Sep 10, 2020Sep 10, 2020Deciphera Pharmaceuticals, Inc.Chief Financial OfficerForm 4 sale9,000$416k56.1%UnusualSEC
May 11, 2020May 13, 2020Deciphera Pharmaceuticals, Inc.Chief Financial OfficerForm 4 sale12,000$662k63.0%UnusualSEC
Jan 3, 2020Jan 6, 2020Deciphera Pharmaceuticals, Inc.Chief Financial OfficerForm 4 sale12,000$692k100.0%UnusualSEC
Dec 23, 2019Dec 26, 2019Deciphera Pharmaceuticals, Inc.Chief Financial OfficerForm 4 sale40,000$2.7M100.0%UnusualSEC
Oct 28, 2019Oct 30, 2019Deciphera Pharmaceuticals, Inc.Chief Financial OfficerForm 4 sale3,750$150k100.0%UnusualSEC
Sep 11, 2019Sep 13, 2019Deciphera Pharmaceuticals, Inc.Chief Financial OfficerForm 4 sale11,250$393k100.0%UnusualSEC
Aug 13, 2019Aug 13, 2019Deciphera Pharmaceuticals, Inc.Chief Financial OfficerForm 4 sale11,250$464k100.0%UnusualSEC
Jun 19, 2019Jun 21, 2019Deciphera Pharmaceuticals, Inc.Chief Financial OfficerForm 4 sale177$4k100.0%UnusualSEC
Jun 3, 2019Jun 5, 2019Deciphera Pharmaceuticals, Inc.Chief Financial OfficerForm 4 sale2,100$53k100.0%UnusualSEC
May 22, 2019May 23, 2019Deciphera Pharmaceuticals, Inc.Chief Financial OfficerForm 4 sale1,473$37k100.0%UnusualSEC
May 1, 2019May 3, 2019Deciphera Pharmaceuticals, Inc.Chief Financial OfficerForm 4 sale13,500$310k100.0%UnusualSEC
Feb 19, 2019Feb 20, 2019Deciphera Pharmaceuticals, Inc.Chief Financial OfficerForm 4 sale1,500$45k100.0%UnusualSEC
Jan 7, 2019Jan 9, 2019Deciphera Pharmaceuticals, Inc.Chief Financial OfficerForm 4 sale5,000$126k100.0%UnusualSEC